The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Stericycle Inc

Nasdaq: SRCL
Last

(U.S.) $81.61

Today's change-0.44 -0.54%
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Stericycle Inc

Nasdaq: SRCL
Last

(U.S.) $81.61

Today's change-0.44 -0.54%
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.

Stericycle Inc down (U.S.)$0.44

Stericycle Inc closed lower Monday, dropping (U.S.)$0.44 or 0.54% to (U.S.)$81.61. Shares have lost 2.28% over the last five days, but have gained 5.93% over the last year to date. This security has underperformed the S&P 500 by 49.26% during the last year.

Key company metrics

  • Open(U.S.) $81.67
  • Previous close(U.S.) $82.05
  • High(U.S.) $82.23
  • Low(U.S.) $81.11
  • Bid / Ask-- / --
  • YTD % change+5.93%
  • Volume589,739
  • Average volume (10-day)804,197
  • Average volume (1-month)980,437
  • Average volume (3-month)1,021,374
  • 52-week range(U.S.) $71.52 to (U.S.) $128.94
  • Beta0.12
  • Trailing P/E39.24×
  • P/E 1 year forward17.71×
  • Forward PEG2.15×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.08
Updated March 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.84%

Based on its net profit margin of 5.84%, Stericycle Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.41%Sector:IndustrialsIndustry:Environmental Services

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue906890892874
Total other revenue--------
Total revenue906890892874
Gross profit372379381369
Total cost of revenue534511511505
Total operating expense838766792733
Selling / general / administrative229189194182
Research & development--------
Depreciation / amortization37435926
Interest expense (income), net operating--------
Unusual expense (income)38232824
Other operating expenses, total----0-3
Operating income69125100141
Interest income (expense), net non-operating-25-25-24-24
Gain (loss) on sale of assets--------
Other--------
Income before tax3710373116
Income after tax19654678
Income tax, total18382738
Net income19654677
Total adjustments to net income-6-3-9-10
Net income before extra. items19654677
Minority interest000-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items13623767
Inc. avail. to common incl. extra. items13623767
Diluted net income13623767
Dilution adjustment----00
Diluted weighted average shares85868686
Diluted EPS excluding extraordinary itemsvalue per share0.150.720.430.78
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.380.890.640.96